| IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy V Suppiah, M Moldovan, G Ahlenstiel, T Berg, M Weltman, ML Abate, ... Nature genetics 41 (10), 1100-1104, 2009 | 2411 | 2009 |
| NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome S Chitturi, S Abeygunasekera, GC Farrell, J Holmes‐Walker, JM Hui, ... Hepatology 35 (2), 373-379, 2002 | 1569 | 2002 |
| Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, ... The Lancet 394 (10215), 2184-2196, 2019 | 1388 | 2019 |
| Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis MD Weltman, GC Farrell, P Hall, M Ingelman-Sundberg, C Liddle Hepatology 27 (1), 128-133, 1998 | 805 | 1998 |
| The brain–gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study NA Koloski, M Jones, J Kalantar, M Weltman, J Zaguirre, NJ Talley Gut 61 (9), 1284-1290, 2012 | 796 | 2012 |
| Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction MM Richardson, JR Jonsson, EE Powell, EM Brunt, ... Gastroenterology 133 (1), 80-90, 2007 | 555 | 2007 |
| Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation MD Weltman, GC Farrell, C Liddle Gastroenterology 111 (6), 1645-1653, 1996 | 516 | 1996 |
| Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma J Behary, N Amorim, XT Jiang, A Raposo, L Gong, E McGovern, R Ibrahim, ... Nature Communications 12 (1), 187, 2021 | 443 | 2021 |
| Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial J Grebely, O Dalgard, B Conway, EB Cunningham, P Bruggmann, ... The lancet Gastroenterology & hepatology 3 (3), 153-161, 2018 | 348 | 2018 |
| HFE mutations, hepatic iron, and fibrosis: ethnic‐specific association of NASH with C282Y but not with fibrotic severity S Chitturi, M Weltman, GC Farrell, D McDonald, C Liddle, ... Hepatology 36 (1), 142-149, 2002 | 292 | 2002 |
| Global multi-stakeholder endorsement of the MAFLD definition N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ... The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022 | 260 | 2022 |
| Which patients with hepatitis C develop liver complications? MH Khan, GC Farrell, K Byth, R Lin, M Weltman, J George, ... Hepatology 31 (2), 513-520, 2000 | 232 | 2000 |
| Coinfection with hepatitis B and C or B, C and δ viruses results in severe chronic liver disease and responds poorly to terferon‐a treatment MD Weltman, A Brotodihardjo, EB Crewe, GC Farrell, M Bililus, ... Journal of viral hepatitis 2 (1), 39-45, 1995 | 225 | 1995 |
| Duodenal eosinophilia and early satiety in functional dyspepsia: confirmation of a positive association in an A ustralian cohort MM Walker, KR Aggarwal, LSE Shim, M Bassan, JS Kalantar, ... Journal of gastroenterology and hepatology 29 (3), 474-479, 2014 | 221 | 2014 |
| Naltrexone versus acamprosate in the treatment of alcohol dependence: a multi‐centre, randomized, double‐blind, placebo‐controlled trial KC Morley, M Teesson, SC Reid, C Sannibale, C Thomson, N Phung, ... Addiction 101 (10), 1451-1462, 2006 | 221 | 2006 |
| Influence of aging on oral-pharyngeal bolus transit and clearance during swallowing: scintigraphic study IJ Cook, MD Weltman, K Wallace, DW Shaw, E McKay, RC Smart, ... American Journal of Physiology-Gastrointestinal and Liver Physiology 266 (6 …, 1994 | 205 | 1994 |
| Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease M Eslam, AM Hashem, R Leung, M Romero-Gomez, T Berg, GJ Dore, ... Nature communications 6 (1), 6422, 2015 | 195 | 2015 |
| Chronic hepatitis C is associated with peripheral rather than hepatic insulin resistance KL Milner, D van der Poorten, M Trenell, AB Jenkins, A Xu, G Smythe, ... Gastroenterology 138 (3), 932-941. e3, 2010 | 187 | 2010 |
| Modelling the hepatitis C virus epidemic in Australia K Razali, HH Thein, J Bell, M Cooper-Stanbury, K Dolan, G Dore, ... Drug and alcohol dependence 91 (2-3), 228-235, 2007 | 181 | 2007 |
| An association between non‐alcoholic fatty liver disease and polycystic ovarian syndrome MM Brzozowska, G Ostapowicz, MD Weltman Journal of gastroenterology and hepatology 24 (2), 243-247, 2009 | 150 | 2009 |
Jacob GeorgeUniversity of Sydney, Westmead Millennium Institute, Westmead Hospital, University of QueenslandVerified email at sydney.edu.au
